Continuous Non-invasive Glucose Monitoring System for Diabetes Market

Continuous Non-invasive Glucose Monitoring System for Diabetes Market contains market size and forecasts of Continuous Non-invasive Glucose Monitoring System for Diabetes in global, including the following market information:
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Continuous Non-invasive Glucose Monitoring System for Diabetes companies in 2021 (%)
The global Continuous Non-invasive Glucose Monitoring System for Diabetes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Wearable CNGMS Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Continuous Non-invasive Glucose Monitoring System for Diabetes include Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment and San Meditech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Continuous Non-invasive Glucose Monitoring System for Diabetes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market Segment Percentages, by Type, 2021 (%)
Wearable CNGMS
Implantable CNGMS
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market Segment Percentages, by Application, 2021 (%)
Child
Adult
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Non-invasive Glucose Monitoring System for Diabetes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Non-invasive Glucose Monitoring System for Diabetes revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Continuous Non-invasive Glucose Monitoring System for Diabetes revenues share in global market, 2021 (%)
Key companies Continuous Non-invasive Glucose Monitoring System for Diabetes sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Continuous Non-invasive Glucose Monitoring System for Diabetes sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech